Gordon Irving

A Multicenter, Randomized, Double-Blind, Controlled Study of NGX-4010, a High-Concentration Capsaicin Patch, for the Treatment of Postherpetic Neuralgia

Gordon Irving, Miroslav Bačkonja, Edwin Dunteman et al. · Pain Medicine · 2010 · 172 citations · Full text

Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: Results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain

Lynn R. Webster, Jan Peter Jansen, John F. Peppin et al. · Pain · 2008 · 144 citations

Dose-finding Study, Opioid Epidemic, Spontaneous Bowel Movements +22

Description and Predictors of Direct and Indirect Costs of Pain Reported by Cancer Patients

Barry Fortner, Gail A. DeMarco, Gordon Irving et al. · Journal of Pain and Symptom Management · 2003 · 138 citations

Pain Therapy, Pain Syndrome, Indirect Costs +15

Duloxetine, Pregabalin, and Duloxetine Plus Gabapentin for Diabetic Peripheral Neuropathic Pain Management in Patients With Inadequate Pain Response to Gabapentin: An Open-Label, Randomized, Noninferiority Comparison

Robert J. Tanenberg, Gordon Irving, Richard C. Risser et al. · Mayo Clinic Proceedings · 2011 · 122 citations · Full text

Inadequate Pain Response, Noninferiority Comparison, Pain Syndrome +13

Efficacy and Tolerability of Gastric-retentive Gabapentin for the Treatment of Postherpetic Neuralgia

Gordon Irving, Mark P. Jensen, Marilou Cramer et al. · Clinical Journal of Pain · 2009 · 88 citations